23030-39-9

Basic information

• Product Name: 2,3,5-Trimethoxybromobenzene
• Synonyms: 2,3,5-Trimethoxybromobenzene;1-bromo-2,3,5-trimethoxybenzene
• CAS NO: 23030-39-9
• Molecular Formula: C₉H₁₁BrO₃
• Molecular Weight: 247.08584
• Mol File: 23030-39-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 170-173 °C(Press: 25 Torr)
• Appearance: /
• Density: 1.391±0.06 g/cm3(Predicted)
• Solubility: DCM; Ethyl Acetate
• CAS DataBase Reference: 2,3,5-Trimethoxybromobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3,5-Trimethoxybromobenzene(23030-39-9)
• EPA Substance Registry System: 2,3,5-Trimethoxybromobenzene(23030-39-9)

Safety Data

• Hazardous Substances Data: 23030-39-9(Hazardous Substances Data)

Usage

Description

2,3,5-Trimethoxybromobenzene is an organic compound that serves as a key intermediate in the synthesis of various pharmaceuticals and chemicals. It is characterized by its bromine atom and three methoxy groups attached to the benzene ring, which contribute to its reactivity and potential applications in different industries.

Uses

Used in Pharmaceutical Industry:
2,3,5-Trimethoxybromobenzene is used as an intermediate in the synthesis of 2,3,5-Trimethoxyamphetamine (T896885), a derivative of Amphetamine (A634240). 2,3,5-Trimethoxybromobenzene is known for its central nervous system (CNS) stimulant and anorexic properties, making it a controlled substance in the category of stimulants.
In the synthesis process, 2,3,5-Trimethoxybromobenzene plays a crucial role in the production of the desired amphetamine derivative, which can be utilized for its stimulant and appetite-suppressing effects. The compound's structural features allow for further chemical modifications and the development of new drugs with potential therapeutic applications.

Upstream product

• 2973-76-4 5-bromo-4-hydroxy-3-methoxybenzaldehyde 
• 61654-67-9 2,5-dihydroxy-3-methoxy-1-bromobenzene 
• 77-78-1 dimethyl sulfate 
• 93092-14-9 1-bromo-5-hydroxy-2,3-dimethoxybenzene 
• 74-88-4 methyl iodide 
• 6948-30-7 5-bromoveratralaldehyde 
• 100668-76-6 Formic acid 3-bromo-4,5-dimethoxy-phenyl ester 

Downstream Products

• 36873-96-8 2,3,5-trimethoxybenzoic acid 
• 75510-58-6 2,3,5-trimethoxy-benzonitrile 
• 5556-84-3 2,3,5-trimethoxy-benzaldehyde 
• 38790-14-6 1,2,5-trimethoxy-3-methylbenzene 
• 88037-84-7 2,3,5-trimethoxydiphenyl ether 
• 149220-85-9 3-hydroxy-2-(2,3,5-trimethoxyphenylamino)benzoic acid 
• 36873-95-7 2,2',3',5'-Tetramethoxy-diphenylether-4-carbonsaeure 
• 849669-42-7 (1R,2S,4aS,8aS)-2,5,5,8a-Tetramethyl-1-(2,3,5-trimethoxy-benzyl)-decahydro-naphthalen-2-ol 
• 156723-06-7 4-(1-methylethyl)-2,3,5-trimethoxyphenylmethyl alcohol 
• 156723-07-8 2-(1-methylethyl)-1,3,4-trimethoxy-5-(bromomethyl)benzene 
• 156723-05-6 methyl 4-(1-methylethyl)-2,3,5-trimethoxybenzoate 
• 156723-10-3 3-ethenyl-4,4-dimethyl-2-[4-(1-methylethyl)-2,3,5-trimethoxyphenylmethyl]-2-cyclohexenone 
• 156723-08-9 4,4-dimethyl-2-[4-(1-methylethyl)-2,3,5-trimethoxyphenyl-methyl]-1,3-cyclohexanedione 
• 119098-80-5 4,5-dihydro-2-(2,3,5-trimethoxyphenyl)-4,4-dimethyloxazole 

Relevant articles and documents

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS OR PRECURSORS THEREOF

Disclosed are methods, compounds, and compositions useful for increasing autophagy and promoting longevity. The methods, compounds, and compositions relate to urolithins and urolithin precursors and use thereof. Certain urolithins are represented by Formula I, while certain urolithin precursors are represented by Formula IV. The urolithin may be urolithin A, urolithin B, urolithin C, or urolithin D. The urolithin precursor may be ellagic acid or an ellagitannin. The methods include in vivo, ex vivo, and in vitro uses of the compounds and compositions.

2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d] pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance

Gangjee et al. recently reported a novel series of 2-amino-4-methyl-5- phenylethyl substituted-7-benzyl-pyrrolo[2,3-d]pyrimidines, some of which exhibited two digit nanomolar antitumor and antimitotic activity and were not subject to P-glycoprotein (Pgp)

Ga(IIl)-catalyzed cycloisomerization approach to (±)-icetexone and (±)-epi-icetexone

"Chemical eqation presented" A Ga(III)-catalyzed cycloisomerization reaction provides expedient access to a benzannulated cycloheptadiene bearing a cyano group, which has been applied to the syntheses of several icetexane diterpenoids including icetexone